Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids

NCT00240604 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00240604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids
Lead sponsor
Hadassah Medical Organization
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2005
Completion date
October 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose intolerance